US pares back childhood vaccine schedule, citing Denmark model

6 January 2026

The US Department of Health and Human Services has announced a sweeping revision to the childhood vaccination schedule, sharply reducing the number of shots recommended for all children and moving closer to Denmark’s approach. The shift replaces a single universal policy with a tiered framework.

Under the revised guidance from the Centers for Disease Control and Prevention, vaccines are now grouped into those advised for all children, those limited to high-risk groups, and those offered through shared clinical decision-making. Universal recommendations now cover 11 diseases, down from 18 earlier this year.

The CDC continues to back routine vaccination against diphtheria, tetanus, pertussis, Haemophilus influenzae type b, pneumococcal disease, polio, measles, mumps, rubella, chickenpox and human papillomavirus. For HPV, only a single dose is now recommended rather than two.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight



More Features in Pharmaceutical